| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9396 |
| Human Intestinal Absorption | HIA+ | 0.9892 |
| Caco-2 Permeability | Caco2+ | 0.5598 |
| P-glycoprotein Substrate | Non-substrate | 0.7071 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7676 |
| Non-inhibitor | 0.8297 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7677 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7831 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7995 |
| CYP450 2D6 Substrate | Non-substrate | 0.8865 |
| CYP450 3A4 Substrate | Non-substrate | 0.7016 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.8106 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7320 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8751 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.6916 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.6478 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8020 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9192 |
| Non-inhibitor | 0.8645 |
| AMES Toxicity | Non AMES toxic | 0.8470 |
| Carcinogens | Non-carcinogens | 0.9197 |
| Fish Toxicity | High FHMT | 0.5706 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9447 |
| Honey Bee Toxicity | Low HBT | 0.8176 |
| Biodegradation | Ready biodegradable | 0.5000 |
| Acute Oral Toxicity | III | 0.5009 |
| Carcinogenicity (Three-class) | Non-required | 0.5141 |